Biolase Price to Free Cash Flow Ratio 2010-2023 | BIOL
Historical price to free cash flow ratio values for Biolase (BIOL) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Biolase Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-04-26 |
0.15 |
|
0.00 |
| 2023-12-31 |
1.12 |
$-0.01 |
0.00 |
| 2023-09-30 |
1.86 |
$310.10 |
0.01 |
| 2023-06-30 |
7.07 |
$230.27 |
0.03 |
| 2023-03-31 |
28.12 |
$115.69 |
0.24 |
| 2022-12-31 |
65.00 |
$-0.44 |
0.00 |
| 2022-09-30 |
243.00 |
$-91.44 |
0.00 |
| 2022-06-30 |
458.00 |
$-78.44 |
0.00 |
| 2022-03-31 |
883.00 |
$-14.58 |
0.00 |
| 2021-12-31 |
975.00 |
$-0.30 |
0.00 |
| 2021-09-30 |
1598.25 |
$-403.39 |
0.00 |
| 2021-06-30 |
1745.25 |
$-78.55 |
0.00 |
| 2021-03-31 |
2107.25 |
$-319.40 |
0.00 |
| 2020-12-31 |
1041.75 |
$-527.24 |
0.00 |
| 2020-09-30 |
687.75 |
$-812.43 |
0.00 |
| 2020-06-30 |
1157.50 |
$-1,233.97 |
0.00 |
| 2020-03-31 |
937.50 |
$-1,128.02 |
0.00 |
| 2019-12-31 |
1381.75 |
$-1,395.74 |
0.00 |
| 2019-09-30 |
2350.00 |
$-1,425.24 |
0.00 |
| 2019-06-30 |
3675.00 |
$-1,533.73 |
0.00 |
| 2019-03-31 |
5950.00 |
$-1,783.62 |
0.00 |
| 2018-12-31 |
2475.00 |
$-1,781.26 |
0.00 |
| 2018-09-30 |
5175.00 |
$-2,075.93 |
0.00 |
| 2018-06-30 |
3025.00 |
$-2,147.88 |
0.00 |
| 2018-03-31 |
5075.00 |
$-2,855.09 |
0.00 |
| 2017-12-31 |
5330.00 |
$-3,246.85 |
0.00 |
| 2017-09-30 |
7535.00 |
$-3,122.76 |
0.00 |
| 2017-06-30 |
12125.00 |
$-3,148.70 |
0.00 |
| 2017-03-31 |
16875.00 |
$-2,362.43 |
0.00 |
| 2016-12-31 |
17500.00 |
$-2,474.66 |
0.00 |
| 2016-09-30 |
21875.00 |
$-2,540.77 |
0.00 |
| 2016-06-30 |
14625.00 |
$-3,189.03 |
0.00 |
| 2016-03-31 |
16375.00 |
$-3,657.44 |
0.00 |
| 2015-12-31 |
10513.75 |
$-4,199.68 |
0.00 |
| 2015-09-30 |
11250.00 |
$-5,243.25 |
0.00 |
| 2015-06-30 |
21750.00 |
$-6,313.77 |
0.00 |
| 2015-03-31 |
25250.00 |
$-5,505.64 |
0.00 |
| 2014-12-31 |
32875.00 |
$-4,853.55 |
0.00 |
| 2014-09-30 |
31125.00 |
$-4,003.06 |
0.00 |
| 2014-06-30 |
27500.00 |
$-2,713.59 |
0.00 |
| 2014-03-31 |
30125.00 |
$-3,641.20 |
0.00 |
| 2013-12-31 |
35199.01 |
$-3,803.64 |
0.00 |
| 2013-09-30 |
23662.78 |
$-2,200.59 |
0.00 |
| 2013-06-30 |
44085.42 |
$-1,556.42 |
0.00 |
| 2013-03-31 |
48767.33 |
$-1,727.55 |
0.00 |
| 2012-12-31 |
22555.46 |
$-912.57 |
0.00 |
| 2012-09-30 |
20623.52 |
$-2,682.09 |
0.00 |
| 2012-06-30 |
23538.70 |
$-4,051.90 |
0.00 |
| 2012-03-31 |
32550.01 |
$-3,723.87 |
0.00 |
| 2011-12-31 |
30714.89 |
$-5,620.61 |
0.00 |
| 2011-09-30 |
35498.97 |
$-4,654.53 |
0.00 |
| 2011-06-30 |
60219.38 |
$-3,572.85 |
0.00 |
| 2011-03-31 |
56491.19 |
$-4,365.14 |
0.00 |
| 2010-12-31 |
20098.72 |
$-1,890.01 |
0.00 |
| 2010-09-30 |
13437.43 |
$-2,200.10 |
0.00 |
| 2010-06-30 |
17342.33 |
$-1,663.14 |
0.00 |
| 2010-03-31 |
22395.72 |
$617.94 |
36.24 |
| 2009-12-31 |
21936.32 |
$-1,415.95 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
